Re:With a nudge from AI, ketamine emerges as a potential rar...
by pneumonic on Saturday August 07, 2021 @08:03PM
(#28103017)
“I advise strongly against trying to pursue ketamine, commercially or clinically, because of safety concerns and the risk of losing our opportunity to study it rigorously,” said Kolevzon [the clinical director]
Research to gain quality evidence is good, but sometimes other considerations outweigh that. Visible improvement in the sufferers of a rare disease may be such a case.
Research to gain quality evidence is good, but sometimes other considerations outweigh that. Visible improvement in the sufferers of a rare disease may be such a case.